Huaren Pharmaceutical バランスシートの健全性
財務の健全性 基準チェック /56
Huaren Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥986.7M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. Huaren Pharmaceutical's EBIT is CN¥305.8M making its interest coverage ratio 5.9. It has cash and short-term investments of CN¥120.1M.
主要情報
34.8%
負債資本比率
CN¥986.74m
負債
| インタレスト・カバレッジ・レシオ | 5.9x |
| 現金 | CN¥120.10m |
| エクイティ | CN¥2.84b |
| 負債合計 | CN¥2.04b |
| 総資産 | CN¥4.87b |
財務状況分析
短期負債: 300110's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.4B).
長期負債: 300110's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥611.3M).
デット・ツー・エクイティの歴史と分析
負債レベル: 300110's net debt to equity ratio (30.5%) is considered satisfactory.
負債の削減: 300110's debt to equity ratio has increased from 11.2% to 34.8% over the past 5 years.
債務返済能力: 300110's debt is well covered by operating cash flow (39.9%).
インタレストカバレッジ: 300110's interest payments on its debt are well covered by EBIT (5.9x coverage).